Related content

Factors associated with adherence and persistence to bisphosphonate therapy in osteoporosis: a cross-sectional survey

By Carr A.   Thompson P.   Cooper C.  

Osteoporosis International, Vol. 17, Iss. 11, 2006-11 ,pp. : 1638-1644

Springer Publishing Company

Access to resources Recommend Favorite

Weekly versus monthly drug regimens: 1-year compliance and persistence with bisphosphonate therapy

By Gold Deborah T.   Trinh Haian   Safi Wael  

Current Medical Research and Opinion, Vol. 25, Iss. 8, 2009-08 ,pp. : 1831-1839

Informa Healthcare

Access to resources Recommend Favorite

Cost-effectiveness of bisphosphonate therapies for women with postmenopausal osteoporosis: implications of improved persistence with less frequently administered oral bisphosphonates

By Earnshaw S. R.   Graham C. N.   Ettinger B.   Amonkar M. M.   Lynch N. O.   Middelhoven H.  

Current Medical Research and Opinion, Vol. 23, Iss. 10, 2007-10 ,pp. : 2517-2529

Informa Healthcare

Access to resources Recommend Favorite

Predictors of non-adherence to systemic oral therapy for advanced hepatocellular carcinoma

By Mallick Rajiv   Cai Jennifer   Wogen Jenifer  

Current Medical Research and Opinion, Vol. 29, Iss. 12, 2013-12 ,pp. : 1701-1708

Informa Healthcare

Access to resources Recommend Favorite

Update on monthly oral bisphosphonate therapy for the treatment of osteoporosis: focus on ibandronate 150 mg and risedronate 150 mg

By Epstein S.   Jeglitsch M.   McCloskey E.  

Current Medical Research and Opinion, Vol. 25, Iss. 12, 2009-12 ,pp. : 2951-2960

Informa Healthcare

Access to resources Recommend Favorite